latest update:
[TrialBase DB]

trial summary · NCT04806347

Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults

TCRαβ+ and CD19+ Depleted Hematopoietic Stem Cell Transplant From Closely Matched Unrelated Donors or Haploidentical Related Donors for Hematologic Diseases in Children and Young Adults

Trial record from the TrialBase DB dataset, status RECRUITING, condition Blood Disease, sponsored by University of Wisconsin, Madison. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT04806347phase PHASE1enrollment 12start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This study is being done to see if the investigators can take peripheral blood stem cells from either an adult family member or a closely matched unrelated donor, and run them through a special lab instrument to remove alpha/beta T cells and B cells and then give them to the patient to treat disease. This is an experimental way of doing a hematopoietic stem cell transplant (HSCT). The investigators want to see if the new stem cells will grow without bad graft vs. host disease (GVHD). This treatment approach is experimental in the United States.

Source record: https://clinicaltrials.gov/study/NCT04806347

Facts

registry idNCT04806347
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionBlood Disease
sponsorUniversity of Wisconsin, Madison
sponsor classOTHER
enrollment12
start date2026-11
primary completion2029-06
completion2030-06
results postednot reported

Conditions

  • Blood Disease

Interventions

  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System

Countries

  • United States

Intervention types: BIOLOGICAL, DEVICE

Work with this record